Search results
15 sie 2024 · Women (people assigned female sex at birth) accounted for 18% (7,046) of the 37,981 new HIV diagnoses in the United States and 6 territories and freely associated states in 2022. Black/African American females aged ≥ 13 years accounted for 50% of new HIV diagnoses among people assigned female sex at birth.
5 mar 2024 · HIV diagnoses decreased 6% among women overall from 2015 to 2019. Although trends varied for different groups of women, HIV diagnoses declined for groups most affected by HIV, including Black/African American women and young women aged 13 to 24. HIV diagnoses among women in the US and dependent areas, 2015-2019*
22 kwi 2024 · Men and women who reported heterosexual contact continue to be affected by HIV. In 2022, people reporting heterosexual contact accounted for 22% (8,495) of the 37,981 new HIV diagnoses. Men reporting heterosexual contact accounted for 7% (2,660) of new HIV diagnoses. Women reporting heterosexual contact accounted for 15% (5,835) of new HIV ...
9 mar 2020 · Among women living with HIV in the U.S., 9 in 10 (89%) were aware of their HIV status; however, many were tested late, many years after acquiring HIV, suggesting missed prevention...
20 mar 2021 · HIV prevalence per 100 000 individuals is 800·9 among women who identify as Black, 442·7 among women who identify as being from multiple races, 191·4 among women who identify as Hispanic, and 77·8 among women who identify as American Indian or Alaskan Native, compared with 45·3 among White women. 6 In fact, the CDC estimates that 3900 (93% ...
10 lis 2023 · HIV diagnoses by gender and sexual orientation. In 2021, men received 79.1% of all new HIV diagnoses. Women accounted for 18.3% and transgender women for 2.3%. Transgender men and other gender identities together accounted for less than three-tenths of 1%, per CDC data.
14 gru 2021 · Because there are gaps in epidemiology data for HIV among transgender women, this fact sheet includes the best available data on HIV incidence, prevalence, PrEP use, and receipt of medical care and treatment for this population from CDC’s National HIV Behavioral Surveillance .
